03 Profile
Vital Signsby Bridgehead
Hansard to 9 November 2026 · 31,243 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Academic · Diabetes
Prof. Andrej Janež: no photograph is held, so the academic plate is shown instead.
Academic
Prof. Andrej Janež
Professor
1
0
Oct 2026Nov 2026to date
1
press citation on 1 topic since 4 Oct 2026 · last quoted 4 Oct 2026
02 Quoted on · 1 of 29 topics
Prof. Andrej Janež: key facts
- Kind of voice
- Academic
- Role
- Professor
- Quoted on
- Diabetes
- Tracked press citations
- 1
- Most recently quoted
- 4 Oct 2026
04 The signal · where Prof. Andrej Janež sits on diabetes
Ranked 45= of 100 voices quoted in the press on diabetes, level with 55 others on 1 citation.
Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.
- 1
Douglas TwenefourClinicianHead of Clinical, Diabetes UK11 - 2
Helen KnightRegulatorDirector of Medicines Evaluation, National Institute for Health and Care Excellence (NICE)9 - 3
Parth NarendranAcademicProfessor of Diabetes Medicine; Honorary Consultant Physician (leads the Type 1 Diabetes clinical service at the Queen Elizabeth Hospital Birmingham), University of Birmingham7 - 45=Subrata BasuClinicianClinical director, Central Basildon PCN (Dr)1
- 45=Ahmad HaidarAcademicalgorithm developer1
- 45=Prof. Andrej JanežAcademicProfessor1
- 45=Prof. Karolina Kędzierska-KapuzaAcademicProfessor1
- 45=Boaz HirshbergSector leaderRegeneron's head of clinical development for internal medicine1
Showing the leaders and the ranks around 45=, of 100 voices · See every voice on the topic →
05 On the record · press
What Prof. Andrej Janež has said
By outlet · linked articles
- clinicaltrialvanguard.com1
Where Prof. Andrej Janež has been quoted
- 01Niia Signature Patch Shows 20-Minute Glucose Signal Recovery After Insulin Bolusclinicaltrialvanguard.com · 4 Oct 2026
Verbatim
“Prof. Andrej Janež addressed continuous ketone monitoring specifically in the context of GLP-1 receptor agonist use, a clinically timely question given how widely that drug class is now prescribed.”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
- First UK patient treated with NICE approved TeplizumabUniversity of Birmingham
- Branding update for insulin pensDiabetes Research & Wellness Foundation
- DRWF Events: Register now for Diabetes: A Whole Life BlueprintDiabetes Research & Wellness Foundation
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.